| ［1］ |
Asbell P，Dualan I，Mindel J，et al.Age-related cataract［J］.Lancet，2005，365（9459）：599-609.
|
| ［2］ |
Liu Y C，Wilkins M，Kim T，et al.Cataracts［J］.Lancet，2017，390（10094）：600-612.
|
| ［3］ |
Causes of blindness and vision impairment in 2020 and trends over 30 years，and prevalence of avoidable blindness in relation to VISION 2020：the Right to Sight：an analysis for the Global Burden of Disease Study［J］.Lancet Glob Health，2021，9（2）：e144-e160.
|
| ［4］ |
Foretz M， Guigas B， Viollet B. Metformin： update on mechanisms of action and repurposing potential［J］.Nat Rev Endocrinol，2023，19（8）：460-476.
|
| ［5］ |
Cabreior F，Au C，Leung K，et al.Metformin retards aging in C.elegans by altering microbial folate and methionine metabolism［J］.Cell，2013，153（1）：228-239.
|
| ［6］ |
Yu H，Zhong X，Gao P，et al.The potential effect of metformin on cancer： an umbrella review ［J］. Front Endocrinol（Lausanne），2019，10：617.
|
| ［7］ |
Amin S，Khanna S，Parvar S，et al.Metformin and retinal diseases in preclinical and clinical studies：Insights and review of literature［J］.Exp Biol Med（Maywood），2022，247（4）：317-329.
|
| ［8］ |
Hurley D，Irnaten M，O'brien C.Metformin and glaucoma-review of anti-fibrotic processes and bioenergetics［J］.Cells，2021，10（8）：2131.
|
| ［9］ |
Delamere N，Tamiya S.Lens ion transport：from basic concepts to regulation of Na，K-ATPase activity［J］.Exp Eye Res，2009，88（2）：140-143.
|
| ［10］ |
Andley U.The lens epithelium：focus on the expression and function of the alpha-crystallin chaperones［J］.Int J Biochem Cell Biol，2008，40（3）：317-323.
|
| ［11］ |
Augusteyn R.On the growth and internal structure of the human lens［J］.Exp Eye Res，2010，90（6）：643-654.
|
| ［12］ |
Mcnulty R，Wang H，Mathias R，et al.Regulation of tissue oxygen levels in the mammalian lens［J］.J Physiol，2004，559（Pt3）：883-898.
|
| ［13］ |
Lu A，Duan P，Xie J，et al.Recent progress and research trend of anti-cataract pharmacology therapy：A bibliometric analysis and literature review［J］.Eur J Pharmacol，2022，934：175299.
|
| ［14］ |
Wishart T，Flokis M，Shu D，et al.Hallmarks of lens aging and cataractogenesis［J］.Exp Eye Res，2021，210：108709.
|
| ［15］ |
Murphy M.How mitochondria produce reactive oxygen species［J］.Biochem J，2009，417（1）：1-13.
|
| ［16］ |
Wang C，Wu S，Wu Y，et al.Oxidative stress response elicited by mitochondrial dysfunction：implication in the pathophysiology of aging［J］.Exp Biol Med（Maywood），2013，238（5）：450-460.
|
| ［17］ |
Yang H，Cui Y，Tang Y，et al.Cytoprotective role of humanin in lens epithelial cell oxidative stress-induced injury［J］.Mol Med Rep，2020，22（2）：1467-1479.
|
| ［18］ |
Michael R，Bron A.The ageing lens and cataract：a model of normal and pathological ageing［J］.Philos Trans R Soc Lond B Biol Sci，2011，366（1568）：1278-1292.
|
| ［19］ |
Anbaraki A，Khoshaman K，Ghasemi Y，et al.Preventive role of lens antioxidant defense mechanism against riboflavin-mediated sunlight damaging of lens crystallins［J］.Int J Biol Macromol，2016，91：895-904.
|
| ［20］ |
Picklo M，Long E，Vomhof-dekrey E.Glutathionyl systems and metabolic dysfunction in obesity［J］.Nutr Rev，2015，73（12）：858-868.
|
| ［21］ |
Shiels A，Hejtmancik J.Mutations and mechanisms in congenital and age-related cataracts［J］.Exp Eye Res，2017，156：95-102.
|
| ［22］ |
Kulkarni A，Gubbi S，Barzilai N.Benefits of metformin in attenuating the hallmarks of aging［J］.Cell Metab，2020，32（1）：15-30.
|
| ［23］ |
Lv Z，Guo Y.Metformin and its benefits for various diseases［J］.Front Endocrinol（Lausanne），2020，11：191.
|
| ［24］ |
Dutta S，Shah R，Singhal S，et al.Metformin：A review of potential mechanism and therapeutic utility beyond diabetes［J］.Drug Des Devel Ther，2023，17：1907-1932.
|
| ［25］ |
Vergroesen J，Thee E，Ahmadizar F，et al.Association of diabetes medication with open-angle glaucoma， age-related macular degeneration，and cataract in the rotterdam study［J］.JAMA Ophthalmol，2022，140（7）：674-681.
|
| ［26］ |
Martin-montalvo A，Mercken E，Mitchell S，et al.Metformin improves healthspan and lifespan in mice［J］.Nat Commun，2013，4：2192.
|
| ［27］ |
Onken B，Driscoll M.Metformin induces a dietary restriction-like state and the oxidative stress response to extend C.elegans Healthspan via AMPK，LKB1，and SKN-1［J］.PLoS One，2010，5（1）：e8758.
|
| ［28］ |
Kulkarni A，Aleksic S，Berger D，et al.Geroscience-guided repurposing of FDA-approved drugs to target aging：A proposed process and prioritization ［J］. Aging Cell， 2022， 21（4）：e13596.
|
| ［29］ |
薛朝军，刘克辛.二甲双胍抗肿瘤机制的研究进展［J］.药学学报，2015，50（10）：1210-1216.
|
| ［30］ |
Saavedra D，Aňé-kouri A，Barzilai N，et al.Aging and chronic inflammation：highlights from a multidisciplinary workshop［J］.Immun Ageing，2023，20（1）：25.
|
| ［31］ |
Chen S，Gan D，Lin S，et al.Metformin in aging and agingrelated diseases：clinical applications and relevant mechanisms［J］.Theranostics，2022，12（6）：2722-2740.
|
| ［32］ |
Moreno-navarrete J，Ortega F，Rodriguze-hermosa J，et al.OCT1 Expression in adipocytes could contribute to increased metformin action in obese subjects［J］.Diabetes，2011，60（1）：168-176.
|
| ［33］ |
Sarfstein R，Friedman Y，Attias-geva Z，et al.Metformin downregulates the insulin/IGF-I signaling pathway and inhibits different uterine serous carcinoma（USC）cells proliferation and migration in p53-dependent or-independent manners［J］.PLoS One，2013，8（4）：e61537.
|
| ［34］ |
Cameron A，Morrison V，Levin D，et al.Anti-inflammatory effects of metformin irrespective of diabetes status［J］.Circ Res，2016，119（5）：652-665.
|
| ［35］ |
Yang F，Qin Y，Wang Y，et al.Metformin Inhibits the NLRP3 inflammasome via AMPK/mTOR-dependent effects in diabetic cardiomyopathy［J］.Int JBiol Sci，2019，15（5）：1010-1019.
|
| ［36］ |
Mahammed I，Hollenberg M，Ding H，et al.A critical review of the evidence that metformin is a putative anti-aging drug that enhances healthspan and extends lifespan［J］.Front Endocrinol（Lausanne），2021，12：718942.
|
| ［37］ |
Fang J，Yang J，Wu X，et al.Metformin alleviates human cellular aging by upregulating the endoplasmic reticulum glutathione peroxidase 7 ［J］. Aging Cell， 2018， 17（4）：e12765.
|
| ［38］ |
Hartwig J，Loebel M，Steiner S，et al.Metformin attenuates ROS via FOXO3 activation in immune cells［J］.Front Immunol，2021，12：581799.
|
| ［39］ |
Sabzali M，Eidi A，Khaksari M，et al.Anti-inflammatory，antioxidant，and antiapoptotic action of metformin attenuates ethanol neurotoxicity in the animal model of fetal alcohol spectrum disorders［J］.Neurotox Res，2022，40（2）：605-613.
|
| ［40］ |
Urpilainen E，Kangaskokko J，Puistola U，et al.Metformin diminishes the unfavourable impact of Nrf2 in breast cancer patients with type 2 diabetes［J］.Tumour Biol，2019，41（1）：1010428318815413.
|
| ［41］ |
Bauer P，Duca F，Waise T，et al.Metformin alters upper small intestinal microbiota that impact a glucose-SGLT1-sensing glucoregulatory pathway［J］.Cell Metab，2018，27（1）：101-117.
|
| ［42］ |
Lee H，Lee Y，Kim J，et al.Modulation of the gut microbiota by metformin improves metabolic profiles in aged obese mice［J］.Gut Microbes，2018，9（2）：155-165.
|
| ［43］ |
Kandarakis S，Piperi C，Topouzis F，et al.Emerging role of advanced glycation-end products（AGEs）in the pathobiology of eye diseases［J］.Prog Retin Eye Res，2014，42：85-102.
|
| ［44］ |
Zhou Z，Tang Y，Jin X，et al.Metformin inhibits advanced glycation end products-induced inflammatory response in murine macrophages partly through AMPK activation and RAGE/NFκB pathway suppression ［J］. J Diabetes Res， 2016，2016：4847812.
|
| ［45］ |
Hardie D.AMPK：a target for drugs and natural products with effects on both diabetes and cancer［J］.Diabetes，2013，62（7）：2164-2172.
|
| ［46］ |
Cheang W，Tian X， Wong W， et al. Metformin protects endothelial function in diet-induced obese mice by inhibition of endoplasmic reticulum stress through 5'adenosine monophosphateactivated protein kinase-peroxisome proliferator-activated receptor δpathway［J］.Arterioscler Thromb Vasc Biol，2014，34（4）：830-836.
|
| ［47］ |
Zhao M，Li X，Chen Z，et al.Neuro-protective role of metformin in patients with acute stroke and type 2 diabetes mellitus via AMPK/mammalian target of rapamycin （mTOR） signaling pathway and oxidative stress［J］.Med Sci Monit，2019，25：2186-2194.
|
| ［48］ |
Ren H，Shao Y，Wu C，et al.Metformin alleviates oxidative stress and enhances autophagy in diabetic kidney disease via AMPK/SIRT1-FoxO1 pathway［J］.Mol Cell Endocrinol，2020，500：110628.
|
| ［49］ |
Chin S，Ha I，Rhee S，et al.Clinical characteristics and prevalence of comorbidities according to metformin use in Korean patients with type 2 diabetes［J］.Int J Endocrinol，2020，PMID：32774367.
|
| ［50］ |
燕朱轩，吕洋.二甲双胍在年龄相关性眼病中应用的研究进展［J］.国际眼科杂志，2023，23（5）：768-773.
|
| ［51］ |
王旭，齐艳华.二甲双胍在眼科的应用前景［J］.国际眼科杂志，2017，17（4）：673-676.
|
| ［52］ |
Chen M，Zhang C，Zhou N，et al.Metformin alleviates oxidative stress-induced senescence of human lens epithelial cells via AMPK activation and autophagic flux restoration［J］.J Cell Mol Med，2021，25（17）：8376-8389.
|
| ［53］ |
Chhunchha B，Kubo E，Singh D.Obligatory role of ampk activation and antioxidant defense pathway in the regulatory effects of metformin on cellular protection and prevention of lens opacity［J］.Cells，2022，11（19）：3021.
|
| ［54］ |
Zhang C，Chen M，Zhou N，et al.Metformin prevents H2O2-induced senescence in human lens epithelial B3 cells［J］.Med Sci Monit Basic Res，2020，26：e923391.
|
| ［55］ |
Fu Y，Wu R，Dong S，et al.Metformin protects human lens epithelial cells from high glucose-induced senescence and autophagy inhibition by upregulating SIRT1［J］.Graefes Arch Clin Exp Ophthalmol，2024，262（2）：477-485.
|
| ［56］ |
Chen M，Fu Y，Wang X，et al.Metformin protects lens epithelial cells against senescence in a naturally aged mouse model［J］.Cell Death Discov，2022，8（1）：8.
|
| ［57］ |
Chen Y，Wu T，Ho C，et al.Blocking of SGLT2 to eliminate NADPH-induced oxidative stress in lenses of animals with fructose-induced diabetes mellitus［J］.Int J Mol Sci，2022，23（13）：7142.
|